Monday, October 01, 2007 8:17:23 AM
Recent ACHV News
- Achieve Life Sciences Promotes Jaime Xinos to Chief Commercial Officer to Advance Commercial Readiness of Cytisinicline • GlobeNewswire Inc. • 10/16/2024 12:00:00 PM
- Achieve Life Sciences Announces Completion of Enrollment in ORCA-OL Clinical Trial & Successful Outcome of the First Data Safety Monitoring Committee Meeting • GlobeNewswire Inc. • 10/10/2024 12:00:00 PM
- Achieve Life Sciences Strengthens Leadership with Appointment of Dr. Mark Rubinstein, Nicotine Dependence Expert, as New Head of Medical Affairs • GlobeNewswire Inc. • 10/01/2024 12:45:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/27/2024 08:55:17 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 09/27/2024 08:46:57 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/26/2024 08:39:30 PM
- Achieve Life Sciences Announces Changes in Executive Leadership and Board of Directors • GlobeNewswire Inc. • 08/26/2024 08:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/20/2024 08:11:26 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/20/2024 08:07:58 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/20/2024 08:05:33 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/13/2024 08:08:44 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/13/2024 08:06:08 PM
- Achieve Life Sciences Reports Financial Results for Second Quarter 2024 and Provides Corporate Update • GlobeNewswire Inc. • 08/13/2024 08:01:00 PM
- Achieve Life Sciences Announces FDA Grants Breakthrough Therapy Designation to Cytisinicline for the Treatment of E-Cigarette or Vaping Nicotine Dependence • GlobeNewswire Inc. • 07/31/2024 12:00:06 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/29/2024 12:10:11 PM
- Achieve Life Sciences Announces $20M Loan Refinancing with Silicon Valley Bank • GlobeNewswire Inc. • 07/29/2024 12:00:00 PM
- Achieve Life Sciences to Announce Second Quarter Financial Results and Host Conference Call and Webcast on August 13, 2024 • GlobeNewswire Inc. • 07/25/2024 12:00:00 PM
- Achieve Life Sciences to Present at JonesHealthcare Seaside Summit 2024 • GlobeNewswire Inc. • 07/09/2024 12:00:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 07/09/2024 04:15:14 AM
- Achieve Life Sciences Announces Addition to the U.S. Russell 3000® and Russell Microcap® Indexes • GlobeNewswire Inc. • 07/01/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/06/2024 09:07:23 PM
- Achieve Life Sciences Announces Initiation of ORCA-OL Clinical Trial Evaluating Long-Term Exposure of Cytisinicline in People who Smoke or Use Nicotine E-Cigarettes • GlobeNewswire Inc. • 05/29/2024 12:00:00 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 05/20/2024 09:01:27 PM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 05/17/2024 06:56:31 PM
- Achieve Life Sciences Announces Data from Cytisinicline ORCA-V1 Program to be Presented at Society of General Internal Medicine (SGIM) Annual Meeting • GlobeNewswire Inc. • 05/17/2024 12:00:29 PM
SANUWAVE Announces Reverse Stock Split, Note and Warrant Exchange, and PIPE Offering • SNWV • Oct 18, 2024 9:31 AM
Vocodia Addresses Recent Stock Price Movement and Future Strategic Partnerships • VHAI • Oct 18, 2024 9:00 AM
Mass Megawatts Announces the Start of an Online Discount Solar Energy Equipment Business with Revenue Recognized for the First Time Since Year 2010 in this Fiscal Quarter • MMMW • Oct 18, 2024 7:32 AM
Unitronix Corp Advances DeFi Innovation with Tokenized Real-World Assets Integration • UTRX • Oct 17, 2024 7:38 AM
Mass Megawatts Commences Solar Energy Sales Efforts • MMMW • Oct 16, 2024 7:45 AM
SANUWAVE Health Announces 1-For-375 Reverse Stock Split • SNWV • Oct 16, 2024 7:40 AM